Inventor · disambiguated record
Carsten Behrens
Also filed as: BEHRENS CARSTEN
18 granted patents·34 pending applications·313 citations·filing 2000–2024
94Inventor score
Files withNOVO NORDISK AS21NOVO NORDISK HEALTHCARE AG14BEHRENS CARSTEN3ANDERSEN HENRIK SUNE1BUCHARDT JENS1
Top patents by PatentIndex Score
52 records- 0195US6875760B2Glucagon antagonists/inverse agonistsNOVO NORDISK AS·Filed 2002·Granted Apr 5, 2005·56 cites·80 claims
- 0295US6503949B1Glucagon antagonists/inverse agonistsNORO NORDISK AS·Filed 2000·Granted Jan 7, 2003·67 cites·56 claims
- 0394US6953812B2Glucagon antagonists/inverse agonistsNOVO NORDISK INC·Filed 2003·Granted Oct 11, 2005·56 cites·54 claims
- 0492US8779109B2Growth hormones with prolonged in-vivo efficacyNOVO NORDISK HEALTHCARE AG·Filed 2013·Granted Jul 15, 2014·17 cites·11 claims
- 0592US6562807B2Glucagon antagonists/inverse agonistsNOVO NORDISK AS·Filed 2001·Granted May 13, 2003·28 cites·70 claims
- 0691US6881746B2Glucagon antagonists/inverse agonistsNOVO NORDISK AS·Filed 2003·Granted Apr 19, 2005·35 cites·32 claims
- 0790US9370583B2Coagulation factor VII polypeptidesNOVO NORDISK HEALTHCARE AG·Filed 2015·Granted Jun 21, 2016·4 cites·10 claims
- 0887US11767332B2Glucose-sensitive albumin-binding derivativesNOVO NORDISK AS·Filed 2021·Granted Sep 26, 2023·1 cites·3 claims
- 0987US6649641B2Glucagon antagonists/inverse agonistsNOVO NORDISK AS·Filed 2001·Granted Nov 18, 2003·18 cites·55 claims
- 1086US11186595B2Glucose-sensitive albumin-binding derivativesNOVO NORDISK AS·Filed 2018·Granted Nov 30, 2021·3 cites·13 claims
- 1185US6927214B1Non-peptide GLP-1 agonistsNOVO NORDISK AS·Filed 2000·Granted Aug 9, 2005·17 cites·27 claims
- 1281US12227528B2Glucose-sensitive albumin-binding derivativesNOVO NORDISK AS·Filed 2023·Granted Feb 18, 2025·0 cites·4 claims
- 1381US2025122226A1Glucose-sensitive albumin-binding derivativesNOVO NORDISK AS·Filed 2024·Application pending·0 cites
- 1480US9018166B2Conjugated FVIII variantsBEHRENS CARSTEN·Filed 2011·Granted Apr 28, 2015·2 cites·9 claims
- 1580US8053410B2Pegylated factor VII glycoformsNOVO NORDISK HEALTH CARE A G·Filed 2009·Granted Nov 8, 2011·4 cites·2 claims
- 1677US8865868B2Conjugated proteins with prolonged in vivo efficacyBEHRENS CARSTEN·Filed 2009·Granted Oct 21, 2014·4 cites·9 claims
- 1775US2020102568A1Growth Hormones with Prolonged In-Vivo EfficacyNOVO NORDISK HEALTHCARE AG·Filed 2019·Application pending·0 cites
- 1870US9695226B2Growth hormones with prolonged in-vivo efficacyBEHRENS CARSTEN·Filed 2011·Granted Jul 4, 2017·1 cites·14 claims
- 1968US2009240028A1Synthesis and Application of New Structural Well Defined Branched Polymers as Conjugating Agents for PeptidesNOVO NORDISK AS·Filed 2008·Application pending·0 cites
- 2064US2010028939A1Use of Galactose Oxidase for Selective Chemical Conjugation of Protractor Molecules to Proteins of Therapeutic InterestNOVO NORDISK HEALTHCARE AG·Filed 2008·Application pending·0 cites
- 2164US2014274903A1Use of galactose oxidase for selective chemical conjugation of protractor molecules to proteins of therapeutic interestNOVO NORDISK HEALTHCARE AG·Filed 2014·Application pending·0 cites
- 2263US2019203213A1Growth Hormones with Prolonged In-Vivo EfficacyNOVO NORDISK HEALTHCARE AG·Filed 2019·Application pending·0 cites
- 2360US2009143592A1Glucagon Antagonists/Inverse AgonistsNOVO NORDISK AS·Filed 2007·Application pending·0 cites
- 2460US2006182714A1Synthesis and application of new structural well defined branched polymers as conjugating agents for peptidesNOVO NORDISK AS·Filed 2006·Application pending·0 cites
- 2559US10179905B2Factor VII conjugatesNOVO NORDISK HEALTHCARE AG·Filed 2017·Granted Jan 15, 2019·0 cites·14 claims
- 2659US2015259665A1Factor vii conjugatesNOVO NORDISK HEALTHCARE AG·Filed 2013·Application pending·0 cites
- 2759US2008039373A1Pegylated Factor VII GlycoformsNOVO NORDISK AS·Filed 2007·Application pending·0 cites
- 2858US2006198819A1Use of galactose oxidase for selective chemical conjugation of protractor molecules to proteins of therapeutic interestNOVO NORDISK HEALTHCARE AG·Filed 2006·Application pending·0 cites
- 2958US2005256175A1Novel glucagon antagonists/inverse agonistsLAU JESPER·Filed 2005·Application pending·0 cites
- 3058US2017239362A1Growth Hormones with Prolonged In-Vivo EfficacyNOVO NORDISK HEALTHCARE AG·Filed 2017·Application pending·0 cites
- 3156US2010056428A1Modified proteinsNOVO NORDISK HEALTHCARE AG·Filed 2007·Application pending·0 cites
- 3254US2005203108A1Glucagon antagonists/inverse agonistsFiled 2004·Application pending·0 cites
- 3353US2009036353A1Insulin Derivatives Conjugated with Structurally Well Defined Branched PolymersNOVO NORDISK AS·Filed 2006·Application pending·0 cites
- 3451US2015224203A1Factor VIII ConjugatesNOVO NORDISK AS·Filed 2015·Application pending·0 cites
- 3550US2003229128A1Glucagon receptor antagonists/inverse agonistsFiled 2002·Application pending·0 cites
- 3650US2003212119A1Novel glucagon receptor antagonists/inverse agonistsFiled 2002·Application pending·0 cites
- 3750US2016251409A1Targeted Delivery of Factor VIII Proteins to PlateletsNOVO NORDISK AS·Filed 2016·Application pending·0 cites
- 3849US2017035890A1Coagulation Factor IX ConjugatesNOVO NORDISK HEALTHCARE AG·Filed 2015·Application pending·0 cites
- 3949US2005113565A1Pegylated factor VII glycoformsFiled 2003·Application pending·0 cites
- 4048US2004116483A1Glucagon antagonists/inverse agonistsFiled 2003·Application pending·0 cites
- 4148US2016120953A1Factor VIII ConjugatesNOVO NORDISK AS·Filed 2015·Application pending·0 cites
- 4246US2016120997A1Modified Glycoproteins Having Circulating Half-LivesNOVO NORDISK HEALTHCARE AG·Filed 2015·Application pending·0 cites
- 4346US2015225710A1Coagulation Factor IX ConjugatesNOVO NORDISK AS·Filed 2015·Application pending·0 cites
- 4444US2022184184A1Glucose sensitive insulin derivativesNOVO NORDISK AS·Filed 2020·Application pending·0 cites
- 4543US2004152750A1Novel glucagon antagonistsFiled 2003·Application pending·0 cites
- 4641US2003203946A1Glucagon antagonists/inverse agonistsFiled 2002·Application pending·0 cites
- 4741US2008108557A1Modified ProteinsNOVO NORDISK HEALTHCARE AG·Filed 2005·Application pending·0 cites
- 4841US2012093840A1Targeted delivery of factor viii proteins to plateletsOESTERGAARD HENRIK·Filed 2010·Application pending·0 cites
- 4940US2008275066A1Condensed Thiophene Derivatives and Their Use as Cyclic Glp-1 AgonistsNOVO NORDISK AS·Filed 2005·Application pending·0 cites
- 5036US2015225711A1Factor VII ConjugatesNOVO NORDISK AS·Filed 2015·Application pending·0 cites
Showing the top 50 of 52 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Carsten Behrens files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →